These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3752759)

  • 1. Symptomatic osteoporosis in a man with hyperprolactinemic hypogonadism.
    Jackson JA; Kleerekoper M; Parfitt AM
    Ann Intern Med; 1986 Oct; 105(4):543-5. PubMed ID: 3752759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoporosis in men with hyperprolactinemic hypogonadism.
    Greenspan SL; Neer RM; Ridgway EC; Klibanski A
    Ann Intern Med; 1986 Jun; 104(6):777-82. PubMed ID: 3706929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of gonadal steroids to bone mass in men with hyperprolactinemic hypogonadism.
    Greenspan SL; Oppenheim DS; Klibanski A
    Ann Intern Med; 1989 Apr; 110(7):526-31. PubMed ID: 2923387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vanishing testes syndrome-related osteoporosis and high cardio-metabolic risk in an adult male with long term untreated hypergonadotropic hypogonadism.
    Carsote M; Capatina C; Valea A; Dumitrascu A
    Arch Endocrinol Metab; 2016 Feb; 60(1):79-84. PubMed ID: 26909487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bone tissue in patients with hyperprolactinemic hypogonadism].
    Rozhinskaia LIa; Marova EI; Dzeranova LK; Rassokhin BM; Purtova GS; Goncharov NP; Mishchenko BP; Ilovaĭskaia IA
    Probl Endokrinol (Mosk); 1992; 38(6):17-9. PubMed ID: 1302840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Infertility Due to Hyperprolactinemia in Empty Sella : A Case Report].
    Kazama T; Yasuda K; Kimura H
    Hinyokika Kiyo; 2019 Feb; 65(2):55-59. PubMed ID: 31067844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoporosis in men with idiopathic hypogonadotropic hypogonadism.
    Finkelstein JS; Klibanski A; Neer RM; Greenspan SL; Rosenthal DI; Crowley WF
    Ann Intern Med; 1987 Mar; 106(3):354-61. PubMed ID: 3544993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and magnitude of osteopenia in patients with prolactinoma.
    Kayath MJ; Lengyel AM; Vieira JG
    Braz J Med Biol Res; 1993 Sep; 26(9):933-41. PubMed ID: 8298528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone histomorphometry in hypogonadal and eugonadal men with spinal osteoporosis.
    Jackson JA; Kleerekoper M; Parfitt AM; Rao DS; Villanueva AR; Frame B
    J Clin Endocrinol Metab; 1987 Jul; 65(1):53-8. PubMed ID: 3584399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism.
    Finkelstein JS; Klibanski A; Neer RM; Doppelt SH; Rosenthal DI; Segre GV; Crowley WF
    J Clin Endocrinol Metab; 1989 Oct; 69(4):776-83. PubMed ID: 2674186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoporosis in hypogonadal men: role of decreased plasma 1,25-dihydroxyvitamin D, calcium malabsorption, and low bone formation.
    Francis RM; Peacock M; Aaron JE; Selby PL; Taylor GA; Thompson J; Marshall DH; Horsman A
    Bone; 1986; 7(4):261-8. PubMed ID: 3768204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated serum lipids in hypogonadal men with and without hyperprolactinemia.
    Oppenheim DS; Greenspan SL; Zervas NT; Schoenfeld DA; Klibanski A
    Ann Intern Med; 1989 Aug; 111(4):288-92. PubMed ID: 2757313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent bone impairment despite long-term control of hyperprolactinemia and hypogonadism in men and women with prolactinomas.
    Andereggen L; Frey J; Andres RH; Luedi MM; Widmer HR; Beck J; Mariani L; Christ E
    Sci Rep; 2021 Mar; 11(1):5122. PubMed ID: 33664388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoporosis in hemochromatosis: iron excess, gonadal deficiency, or other factors?
    Diamond T; Stiel D; Posen S
    Ann Intern Med; 1989 Mar; 110(6):430-6. PubMed ID: 2919850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rat osteoporotic spine model for the evaluation of bioresorbable bone cements.
    Wang ML; Massie J; Perry A; Garfin SR; Kim CW
    Spine J; 2007; 7(4):466-74. PubMed ID: 17630145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Erectile dysfunction secondary to hyperprolactinemia. Apropos of 13 cases].
    Abram F; Linke F; Kalfon A; Tchovelidze C; Chelbi N; Arvis G
    Prog Urol; 1998 Sep; 8(4):537-41. PubMed ID: 9834517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prolactinomas and bone mineral density in men].
    Naliato EC; Farias ML; Violante AH
    Arq Bras Endocrinol Metabol; 2005 Apr; 49(2):183-95. PubMed ID: 16184246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A longitudinal analysis of premenopausal bone loss in healthy women and women with hyperprolactinemia.
    Schlechte J; Walkner L; Kathol M
    J Clin Endocrinol Metab; 1992 Sep; 75(3):698-703. PubMed ID: 1517357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone loss following hypogonadism in men with prostate cancer treated with GnRH analogs.
    Mittan D; Lee S; Miller E; Perez RC; Basler JW; Bruder JM
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3656-61. PubMed ID: 12161491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacodynamic metoclopramide (cerucal) test in differential diagnosis of hypoprolactinemic hypogonadism syndrome in women].
    Balabolkin MI; Gerasimov GA; Liubimov AV
    Akush Ginekol (Mosk); 1990 Feb; (2):54-7. PubMed ID: 2339765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.